The European Medicines Agency (EMA) has not been capable of attain a choice on the approval of Moderna’s COVID-19 vaccine on Monday, the Dutch nationwide medicines authority stated.
The EMA’s human medicines committee (CHMP) had referred to as an unscheduled assembly Monday afternoon to debate Moderna’s vaccine, two days forward of its initially deliberate assembly on Wednesday.
Visit our devoted coronavirus website right here for all the most recent updates.
The Dutch medicines regulator CBG stated approval might nonetheless comply with on the assembly on Jan 6.
It stated it was not clear why a choice was not reached on Monday.
For all the most recent headlines comply with our Google News channel on-line or by way of the app.
“This is how it goes, of course we had hoped for more, but we knew it could be impossible to answer all questions in detail in one meeting,” CBG chairman Ton de Boer advised reporters.
“I hope there will be a decision on Wednesday. But I don’t know.”
The company has set a Jan. 12 deadline for whether or not to suggest Moderna’s vaccine. It really helpful a COVID-19 vaccine from Pfizer and its German companion BioNTech on Dec. 21.
Read extra:
Coronavirus: Moderna says CDC panel recommends its COVID-19 vaccine for adults
Coronavirus: US FDA raises no new considerations with Moderna’s COVID-19 vaccine
SHOW MORE
Last Update: Tuesday, 05 January 2021 KSA 23:46 – GMT 20:46
